Poland aims to expand cell therapies. Plans include treating several types of cancer
The National Institute of Oncology is developing a therapy using tumor-infiltrating lymphocytes (T cells), and plans are underway to treat several types of cancer.

Julia Koblitz · Unsplash License
- 0views
- 0likes and saves
- 0skips
In brief
- The National Institute of Oncology is developing tumor-infiltrating lymphocyte (TIL) therapy as the first center in this region of Europe.
- The method uses the patient's own immune cells isolated from the tumor.
- Plans cover treatment of several types of cancer; timelines and the number of patients are not yet known.
New method at the National Institute of Oncology
As PAP reported, Prof. Piotr Rutkowski of the National Institute of Oncology said the institute is the first in this region of Europe working on a therapy based on tumor-infiltrating T lymphocytes, or TIL (Polska chce rozwijać terapie komórkowe. W planach leczenie kilku rodzajów raka – Bankier.pl). According to his account, cell therapies are among the newest directions in cancer treatment.
How TIL therapy works
The method uses the patient's own immune cells that are already present in the tumor. T lymphocytes are isolated from the cancer, then expanded so they can be given back to the patient to strengthen the body's response to the disease.
Plans to expand treatment
Poland wants to develop this path so that it covers several types of cancer, not just one indicated type. The report suggests this is still at the planning stage; specific implementation dates and the number of patients to be treated were not given in this account.
What's next
At this stage, the information concerns intentions and research development at a single center. People interested in taking part in experimental treatment should ask their oncologist about available programs and eligibility.
Sources
Discussion0
- No comments from this perspective yet. Be the first.